• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 相关心律失常的全球调查。

Worldwide Survey of COVID-19-Associated Arrhythmias.

机构信息

Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians & Surgeons (E.J.C., S. Kochav, I.G., A.B., H.G., E.Y.W.).

New York Presbyterian Queens, Weill Medical College (S.G., J.-H.K., I.Y.).

出版信息

Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458. doi: 10.1161/CIRCEP.120.009458. Epub 2021 Feb 7.

DOI:10.1161/CIRCEP.120.009458
PMID:33554620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7982128/
Abstract

[Figure: see text].

摘要

[图：见正文]。

相似文献

1
Worldwide Survey of COVID-19-Associated Arrhythmias.COVID-19 相关心律失常的全球调查。
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458. doi: 10.1161/CIRCEP.120.009458. Epub 2021 Feb 7.
2
Cardiac electrophysiology in Egypt.埃及的心脏电生理学。
Heart Rhythm. 2008 Feb;5(2):331. doi: 10.1016/j.hrthm.2007.11.016. Epub 2008 Jan 15.
3
Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.欧洲心脏病学会成员国心脏植入式电子设备的获取与临床应用以及介入性电生理手术：欧洲心律协会2016年报告
Europace. 2016 Aug;18 Suppl 3:iii1-iii79. doi: 10.1093/europace/euw244.
4
Temporary transvenous cardiac pacing: a survey on current practice.临时经静脉心脏起搏：当前实践调查。
J Cardiovasc Med (Hagerstown). 2020 Jun;21(6):420-427. doi: 10.2459/JCM.0000000000000959.
5
Year in Review in Cardiac Electrophysiology.心脏电生理学年度回顾
Circ Arrhythm Electrophysiol. 2018 Jul;11(7):e006648. doi: 10.1161/CIRCEP.118.006648.
6
Exploring New Frontiers in Cardiac Electrophysiology.探索心脏电生理学的新前沿。
Methodist Debakey Cardiovasc J. 2021 Apr 5;17(1):6-7. doi: 10.14797/HMRI6337. Epub 2021 Mar 25.
7
The role of the Arrhythmia Team, an integrated, multidisciplinary approach to treatment of patients with cardiac arrhythmias: results of the European Heart Rhythm Association survey.心律失常团队的作用：一种综合的、多学科的方法，用于治疗心律失常患者：欧洲心律协会调查的结果。
Europace. 2016 Apr;18(4):623-7. doi: 10.1093/europace/euw090.
8
Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort.在一个多元化的纽约市队列中，COVID-19 死亡病例的临床和心脏特征。
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3086-3096. doi: 10.1111/jce.14772. Epub 2020 Oct 20.
9
Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey.冷冻消融治疗心律失常：欧洲心律协会调查结果
Europace. 2017 Feb 1;19(2):303-307. doi: 10.1093/europace/eux001.
10
Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals.全球范围内 153152 名中年人群中心房颤动的患病率、治疗和影响的多中心队列研究。
Cardiovasc Res. 2021 May 25;117(6):1523-1531. doi: 10.1093/cvr/cvaa241.

引用本文的文献

1
The Involvement and Manifestations of SARS-CoV-2 Virus in Cardiovascular Pathology.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒在心血管病理中的参与及表现
Medicina (Kaunas). 2025 Apr 22;61(5):773. doi: 10.3390/medicina61050773.
2
24 h Holter Monitoring and 14-Day Intermittent Patient-Activated Heart Rhythm Recording to Detect Arrhythmias in Symptomatic Patients After Severe COVID-19-A Prospective Observation.24小时动态心电图监测和14天间歇性患者激活式心律记录以检测重症新型冠状病毒肺炎后有症状患者的心律失常——一项前瞻性观察研究
J Clin Med. 2025 Apr 12;14(8):2649. doi: 10.3390/jcm14082649.
3
Cardiac symptoms in patients 3-6 months after contracting COVID-19- data from the polish STOP-COVID registry.感染新冠病毒3至6个月后患者的心脏症状——来自波兰STOP-COVID注册中心的数据
BMC Infect Dis. 2025 Apr 9;25(1):489. doi: 10.1186/s12879-025-10774-0.
4
The cardiovascular effects of interleukin-6 inhibition in patients with severe coronavirus-19 infection.白细胞介素-6抑制对重症冠状病毒-19感染患者心血管系统的影响。
J Int Med Res. 2025 Apr;53(4):3000605251324590. doi: 10.1177/03000605251324590. Epub 2025 Apr 2.
5
Global trends and epidemiological impact of metabolic risk factors on atrial fibrillation and atrial flutter from 1990 to 2021.1990年至2021年代谢危险因素对心房颤动和心房扑动的全球趋势及流行病学影响
Sci Rep. 2025 Feb 7;15(1):4561. doi: 10.1038/s41598-025-88744-4.
6
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据：美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
7
Drug-Drug interactions prediction calculations between cardiovascular drugs and antidepressants for discovering the potential co-medication risks.用于发现潜在联合用药风险的心血管药物与抗抑郁药之间的药物相互作用预测计算。
PLoS One. 2025 Jan 13;20(1):e0316021. doi: 10.1371/journal.pone.0316021. eCollection 2025.
8
Trends in sepsis-associated cardiovascular disease mortality in the United States, 1999 to 2022.1999年至2022年美国脓毒症相关心血管疾病死亡率的趋势
Front Cardiovasc Med. 2024 Dec 9;11:1505905. doi: 10.3389/fcvm.2024.1505905. eCollection 2024.
9
A Multicenter Study Assessing the Optimal Anticoagulation Strategies in COVID-19 Critically Ill Patients with New-Onset Atrial Fibrillation: Balancing Effectiveness and Safety.一项评估新型冠状病毒肺炎（COVID-19）危重症合并新发房颤患者最佳抗凝策略：平衡有效性和安全性的多中心研究
Int J Gen Med. 2024 Nov 28;17:5611-5622. doi: 10.2147/IJGM.S484472. eCollection 2024.
10
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients.白细胞介素-6水平升高与重症COVID-19患者的房室传导延迟有关。
J Arrhythm. 2024 Jul 31;40(5):1137-1148. doi: 10.1002/joa3.13114. eCollection 2024 Oct.

本文引用的文献

1
Anticoagulation outcomes in hospitalized Covid-19 patients: A systematic review and meta-analysis of case-control and cohort studies.住院新冠患者抗凝治疗结局：病例对照和队列研究的系统评价和荟萃分析。
Rev Med Virol. 2021 May;31(3):e2180. doi: 10.1002/rmv.2180. Epub 2020 Oct 6.
2
The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19.心电图在 COVID-19 患者急诊科就诊时的预后价值。
Mayo Clin Proc. 2020 Oct;95(10):2099-2109. doi: 10.1016/j.mayocp.2020.07.028. Epub 2020 Aug 15.
3
COVID-19 can affect the heart.新冠病毒可影响心脏。
Science. 2020 Oct 23;370(6515):408-409. doi: 10.1126/science.abe2813. Epub 2020 Sep 23.
4
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing).COVID-19 大流行对意大利心律失常和电生理学相关临床活动的影响：AIAC（意大利心律失常与心脏起搏协会）发起的一项调查结果。
Intern Emerg Med. 2020 Nov;15(8):1445-1456. doi: 10.1007/s11739-020-02487-w. Epub 2020 Sep 5.
5
Impact of the COVID-19 Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy.新冠疫情对意大利一家三级电生理实验室的影响。
Circ Arrhythm Electrophysiol. 2020 Sep;13(9):e008774. doi: 10.1161/CIRCEP.120.008774. Epub 2020 Jul 23.
6
Extrapulmonary manifestations of COVID-19.COVID-19 的肺外表现。
Nat Med. 2020 Jul;26(7):1017-1032. doi: 10.1038/s41591-020-0968-3. Epub 2020 Jul 10.
7
COVID-19 and cardiac arrhythmias.新型冠状病毒肺炎与心律失常。
Heart Rhythm. 2020 Sep;17(9):1439-1444. doi: 10.1016/j.hrthm.2020.06.016. Epub 2020 Jun 22.
8
COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.新型冠状病毒肺炎与心律失常：心律失常特征及管理策略的全球视角
J Interv Card Electrophysiol. 2020 Nov;59(2):329-336. doi: 10.1007/s10840-020-00789-9. Epub 2020 Jun 3.
9
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.托珠单抗治疗重症 COVID-19 患者的疗效和安全性：一项单中心回顾性队列研究。
Eur J Intern Med. 2020 Jun;76:43-49. doi: 10.1016/j.ejim.2020.05.021. Epub 2020 May 22.
10
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.《纽约市 COVID-19 重症成人的流行病学、临床病程和结局：一项前瞻性队列研究》
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.